Skip to content
healthcare.dev
Get a free key

Flucelvax

NDC 87063-299, INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), injection, suspension, from ASCLEMED USA INC..

Product NDC
87063-299
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125408
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-299 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/TASMANIA/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)15 ug/.5mL
  • INFLUENZA A VIRUS A/TASMANIA/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)15 ug/.5mL
  • INFLUENZA B VIRUS - B/ARIZONA/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)15 ug/.5mL
Package NDCNDC-11Package
87063-299-108706302991010 SYRINGE, GLASS in 1 CARTON (87063-299-10) / .5 mL in 1 SYRINGE, GLASS (87063-299-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87063-299 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-299 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-299. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.